DR. OZLEM EQUILS, M.D.
Medical Practice at Beverly Blvd, Los Angeles, CA
License number
California A55302
Category
Medical Practice
Type
Specialist
Address
Address
2
8700 Beverly Blvd, Los Angeles, CA 90048
5236 Norwich Ave, Van Nuys, CA 91411
5236 Norwich Ave, Van Nuys, CA 91411
Phone
(310) 967-1884
(310) 967-1744 (Fax)
(818) 783-3867
(310) 423-8284 (Fax)
(310) 967-1744 (Fax)
(818) 783-3867
(310) 423-8284 (Fax)
Personal information
See more information about OZLEM EQUILS at radaris.comName
Address
Phone
17050 Rancho St, Encino, CA 91316
25786 Highplains Ter, Laguna Hills, CA 92653
Organization information
See more information about OZLEM EQUILS at bizstanding.comOzlem Equils MD
8700 Beverly Blvd, Los Angeles, CA 90048
Industry:
Pediatrician
Site:
Phone:
(310) 423-4471 (Phone)
Description:
There are 4 doctors at this site. Surgery is not performed at this site.
Ozlem Kahyaoglu Equils
Professional information
Consultant At Cellworks Group Inc
Position:
Doctor at Cedars-Sinai Medical Center, Medical Director at Pfizer, Institutional Biosafety Committee Member at Cedars-Sinai Medical Center, Speaker at Sanofi Pasteur
Location:
Greater Los Angeles Area
Industry:
Medical Practice
Work:
Cedars-Sinai Medical Center
-
Doctor
Pfizer
since 2009
-
Medical Director
Cedars-Sinai Medical Center
since Jun 2008
-
Institutional Biosafety Committee Member
Sanofi Pasteur
since Jun 2006
-
Speaker
Cedars-Sinai Medical Center
Jun 2004 - Jun 2008
-
Institutional Review (Ethics) Committee Member
Education:
University of California, Los Angeles 1996 - 1999
Fellowship, Pediatric Infectious Diseases Michigan State University College of Human Medicine 1993 - 1996
Resident, Pediatrics Hacettepe Üniversitesi 1985 - 1991
Fellowship, Pediatric Infectious Diseases Michigan State University College of Human Medicine 1993 - 1996
Resident, Pediatrics Hacettepe Üniversitesi 1985 - 1991
Interests:
JOURNAL REVIEWER
Pediatrics, Journal of Infectious Diseases, Journal of Immunology, Pediatric Research, International Journal of Medical Sciences, Infection and Immunity, AIDS Research and Human Retroviruses, Clinical Infectious Diseases
Honor & Awards:
1. Housestaff Assoc. Certificate - Hurley Medical Center 1996
2. Active Resident Investigator Award 1996
3. Michigan State Univ./Hurley Medical Center
Frank V. Hodges Research Award 1996
4. Information Technology in Patient Care Award 1996
5. Michigan State Univ./Hurley Medical Center
6. Pediatric Infectious Diseases Society Fellowship Award 1997
7. Fellow Travel Award 1998
(6th Conference on Retroviruses & Opportunistic Infections)
8. George McCracken Scholar 1998
(38th ICAAC Meeting)
9. Ahmanson Endowment Award 1999
10. UCLA NIH Child Health Research Center Award 2000, 2001 and 2002
11. Howard Hughes Award 2003
12. American Association of Immunologists Travel Award 2005
Owner, Rpi Biotech Inc
Position:
Owner at RPI Biotech Inc
Location:
Greater Los Angeles Area
Industry:
Pharmaceuticals
Work:
RPI Biotech Inc
-
Owner
Dr. Ozlem Equils, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Pediatrics
Address:
8700 Beverly Blvd SUITE 4221, Los Angeles 90048
(310) 967-1884 (Phone), (310) 967-1744 (Fax)
Los Angeles Office
8700 Beverly Blvd, Los Angeles 90048
(800) 233-2771 (Phone), (310) 659-3928 (Fax)
(310) 967-1884 (Phone), (310) 967-1744 (Fax)
Los Angeles Office
8700 Beverly Blvd, Los Angeles 90048
(800) 233-2771 (Phone), (310) 659-3928 (Fax)
Certifications:
Pediatrics, 2011
Awards:
Healthgrades Honor Roll
Languages:
English, Turkish
Education:
Medical School
Ankara Universitesi, Tip Fakultesi
Graduated: 1991
Ankara Universitesi, Tip Fakultesi
Graduated: 1991
Ozlem Kahyaoglu Equils, West Hollywood CA
Specialties:
Pediatrics, Pediatric Infectious Diseases, Infectious Disease
Work:
Cedars-Sinai Medical Center
8700 Beverly Blvd, Los Angeles, CA 90048
8700 Beverly Blvd, Los Angeles, CA 90048
Education:
Hacettepe Universitesi (1991)
Ozlem Equils, West Hollywood CA
Specialties:
Pediatrician
Address:
8700 Beverly Blvd, West Hollywood, CA 90048
Education:
Doctor of Medicine*
Board certifications:
American Board of Pediatrics Certification in Pediatrics*
Diagnostic Biomarker To Identify Women At Risk For Preterm Delivery
US Patent:
2012023, Sep 20, 2012
Filed:
Dec 7, 2010
Appl. No.:
13/512212
Inventors:
Ozlem Equils - Sherman Oaks CA, US
Charles F. Simmons - Los Angeles CA, US
Charles F. Simmons - Los Angeles CA, US
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
C40B 30/04, C40B 40/10, C12Q 1/06, G01N 33/566, C12Q 1/68
US Classification:
506 9, 435 792, 435 611, 435 39, 506 18
Abstract:
The invention relates to biomarkers associated with preterm delivery. More specifically, the invention provides methods of measuring biomarkers found in women that are at risk for preterm delivery.
Diagnostic Biomarker To Predict Women At Risk For Preterm Delivery
US Patent:
2014005, Feb 20, 2014
Filed:
Mar 13, 2012
Appl. No.:
14/003334
Inventors:
Ozlem Equils - Sherman Oaks CA, US
Charles F. Simmons - Los Angeles CA, US
Charles F. Simmons - Los Angeles CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
G01N 33/68
US Classification:
506 9, 435 71, 435 724, 435 792, 435 61, 530350
Abstract:
The invention relates to biomarkers associated with preterm delivery. More specifically, the invention provides methods of measuring biomarkers including but not limited to cytokines, cytokine receptors, cytokine receptor antagonists, chemokines, chemokine receptors, and/or chemokine receptor antagonists found in women that are at risk for preterm delivery. The diagnostic methods may be performed on whole blood.
Method Of Treating Inflammation With Hiv-1 Protease Inhibitors And Their Derivatives
US Patent:
2003013, Jul 24, 2003
Filed:
Nov 27, 2002
Appl. No.:
10/306000
Inventors:
Moshe Arditi - Encino CA, US
Ozlem Equils - Sherman Oaks CA, US
Ozlem Equils - Sherman Oaks CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER
International Classification:
A61K039/395, A61K031/415, A61K031/551
US Classification:
424/145100, 514/220000, 514/406000
Abstract:
Disclosed herein are methods of treating inflammation by administering to a patient an HIV-protease inhibitor. While protease inhibitors are known for their capacity to prevent or significantly hinder the cleavage of proteins that would otherwise become smaller viral particles, certain of these inhibitors may also be employed in the treatment of inflammation and diseases in which an inflammatory response is evident. Further methods are directed to the treatment of disease conditions in which it may be advantageous to down-modulate NF- B cell signal transduction.
Caspase Inhibitors In The Treatment Of Infection-Associated Preterm Delivery
US Patent:
2010029, Nov 18, 2010
Filed:
May 1, 2008
Appl. No.:
12/598259
Inventors:
Ozlem Equils - Sherman Oaks CA, US
Calvin Hobel - Palos Verdes Estates CA, US
Charles F. Simmons - Los Angeles CA, US
Calvin Hobel - Palos Verdes Estates CA, US
Charles F. Simmons - Los Angeles CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
A61K 38/06, A61P 15/00
US Classification:
514 219
Abstract:
Apoptotic processes induced by infection of, or injury to, fetal and placental tissues have been implicated in preterm delivery. Thus, modulation of apoptotis constitutes a strategy for improving pregnancy outcome in women with intrauterine infections. Caspase inhibitors, including the pancaspase inhibitor Z-VAD-FMK, can be used to prevent apoptosis and, thus, prevent preterm delivery. Accordingly, compositions and methods comprising caspase inhibitors for prevention of preterm delivery are provided.
Teething Device
US Patent:
2006025, Nov 9, 2006
Filed:
May 6, 2005
Appl. No.:
11/124302
Inventors:
Ozlem Equils - Sherman Oaks CA, US
International Classification:
A61J 17/00
US Classification:
606235000
Abstract:
A teething device incorporating a vibratory unit and a brush unit is disclosed for use by an infant during the teething process or as a toothbrush. The teething device includes a body generally formed from two interlocking pieces, with the brush unit disposed on the top of the teething device. An interior chamber of the teething device holds a motor configured to generate vibratory forces which resonate through the brush unit to massage the gums of the infant. The brush unit is angled relative to a base of the teething device to facilitate use by the infant. The brush unit may further include one or more holes in communication with a reservoir disposed in the body, the holes being dimensioned to dispense a liquid during use of the teething device.